Histopathology Services Market to Grow at a CAGR of 5.7% to reach US$ 35,187.90 Million from 2021 to 2028
Le marché des services d'histopathologie devrait atteindre 35 187,90 millions de dollars US d'ici 2028, contre 23 890,44 millions de dollars US en 2021 ; il devrait croître à un TCAC de 5,7 % de 2021 à 2028.
Les services d'histopathologie sont utilisés pour l'examen microscopique des tissus biologiques lors du diagnostic des maladies. Grâce aux techniques d’imagerie, des tissus biopsiques peuvent être obtenus à partir de certains sites inaccessibles, comme le pancréas et le péritoine.Des facteurs tels que la demande croissante de produits biologiques et la prévalence croissante des maladies chroniques stimulent la croissance du marché des services d'histopathologie . Cependant, les limitations associées à l’histopathologie et à l’immunohistochimie devraient restreindre dans une certaine mesure la croissance du marché au cours de la période de prévision.
Personnalisez la recherche en fonction de vos besoins
Nous pouvons optimiser et adapter l’analyse et la portée qui ne sont pas satisfaites par nos offres standard. Cette flexibilité vous aidera à obtenir les informations exactes nécessaires à la planification de votre entreprise et à la prise de décision.
Marché des services d’histopathologie : perspectives stratégiques
TCAC (2021 - 2028)5,7%- Taille du marché 2021
23,89 milliards de dollars américains - Taille du marché 2028
35,19 milliards de dollars américains
Dynamique du marché
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Joueurs clés
- Sonic Healthcare Limitée
- Laboratoire Corporation of America Holdings
- Acculabs Diagnostics UK Ltd.
- Laboratoires de chemin TPL
- UNILABS
- Cureline CRO translationnelle mondiale
- Targos
- Services de pathologie cellulaire,
- Laboratoires de pathologie expérimentale Inc (EPL)
Aperçu régional
- Amérique du Nord
- L'Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
- Moyen-Orient et Afrique
Segmentation du marché
- Spécimen chirurgical
- Biopsie mammaire
- Biopsie pulmonaire
- Biopsie rénale
- Biopsie gastro-intestinale
- Biopsie pancréatique
- Biopsie des tissus cutanés
- Biopsie testiculaire
- Autres
- Laboratoires de diagnostic et laboratoires de référence
- Instituts de recherche
- Autres
- Amérique du Nord
- L'Europe
- Asie-Pacifique
- Moyen-Orient et Afrique
- Amérique du Sud et Centrale
- L'exemple de PDF présente la structure du contenu et la nature des informations avec une analyse qualitative et quantitative.
Aperçus du marché
Prévalence croissante des maladies chroniques
Les maladies chroniques telles que les troubles cardiovasculaires, les troubles neurologiques, les maladies auto-immunes et le cancer sont la principale cause de décès et d'invalidité dans le monde. Selon les Centers for Disease Control and Prevention, en 2019, près de 6 personnes sur 10 souffraient d’au moins une maladie chronique aux États-Unis. Selon l'Organisation mondiale de la santé (OMS), les maladies cardiovasculaires sont la première cause de décès dans le monde, tuant environ 17,9 millions de personnes chaque année.
Le cancer est l’une des principales causes de mortalité dans le monde, ce qui représente un énorme fardeau financier pour la société. Selon l’OMS, en 2018, environ 9,6 millions de décès sont survenus à cause du cancer dans le monde. Cependant, la recherche croissante sur le développement de traitements efficaces contre la maladie influence la croissance du marché. Selon le profil national de santé, les cas de cancers courants, notamment les cancers du col de l'utérus, de la bouche et du sein, ont augmenté de 324 % en Inde entre 2017 et 2018. De plus, le nombre total de patients visitant les cliniques de maladies non transmissibles (MNT) ont doublé entre 2017 et 2018, pour atteindre respectivement 35 millions et 66 millions. L’évolution rapide du mode de vie et la consommation d’alcool et de produits du tabac comptent parmi les principaux facteurs augmentant l’incidence du cancer au sein de la population.
Les maladies auto-immunes contribuent en outre à ce qu’un nombre important de populations souffrent de divers types de maladies. Par exemple, selon les National Institutes of Health, environ 23,5 millions d’Américains souffrent de maladies auto-immunes, et 8 millions de personnes supplémentaires ont des auto-anticorps dans les molécules sanguines qui indiquent le risque de développer une maladie auto-immune. La cause sous-jacente de diverses maladies auto-immunes est encore inconnue. Ainsi, les chercheurs et les thérapeutes traitant et explorant des thérapies pour ces maladies effectuent des analyses histopathologiques détaillées pour comprendre le mécanisme des maladies et concevoir des thérapies et des traitements pour leur prise en charge. Ainsi, le nombre croissant de maladies chroniques dans le monde devrait expliquer la croissance du marché des services histopathologiques au cours de la période de prévision.
Informations basées sur le type d'examen
En fonction du type d’examen, le marché des services d’histopathologie est classé en spécimen chirurgical, biopsie mammaire, biopsie pulmonaire, biopsie rénale, biopsie gastro-intestinale, biopsie pancréatique, biopsie des tissus cutanés, biopsie testiculaire et autres. En 2021, le segment des échantillons chirurgicaux détenait la plus grande part du marché et devrait connaître la croissance la plus rapide au cours de la période de prévision.
Informations basées sur l'utilisateur final
En fonction de l’utilisateur final, le marché des services d’histopathologie a été segmenté en laboratoires de diagnostic et laboratoires de référence, instituts de recherche et autres. En 2021, le segment des laboratoires de diagnostic et des laboratoires de référence détenait la plus grande part du marché et devrait croître à un TCAC significatif au cours de la période de prévision.
Diverses entreprises opérant sur le marché des services d'histopathologie adoptent des stratégies telles que des lancements de produits, des fusions et acquisitions, des collaborations, des innovations de produits et des expansions de portefeuille de produits pour étendre leur empreinte dans le monde entier, maintenir leur marque et répondre à la demande croissante des utilisateurs finaux.
Portée du rapport sur le marché des services d’histopathologie
Attribut de rapport | Détails |
---|---|
Taille du marché en 2021 | 23,89 milliards de dollars américains |
Taille du marché d’ici 2028 | 35,19 milliards de dollars américains |
TCAC mondial (2021 - 2028) | 5,7% |
Données historiques | 2019-2020 |
Période de prévision | 2022-2028 |
Segments couverts | Par type d'examen
|
Régions et pays couverts | Amérique du Nord
|
Leaders du marché et profils d’entreprises clés |
|
- L'exemple de PDF présente la structure du contenu et la nature des informations avec une analyse qualitative et quantitative.
Marché des services d’histopathologie – par type d’examen
- Spécimen chirurgical
- Biopsie mammaire
- Biopsie pulmonaire
- Biopsie rénale
- Biopsie gastro-intestinale
- Biopsie pancréatique
- Biopsie des tissus cutanés
- Biopsie testiculaire
- Autres
Marché des services d’histopathologie – par utilisateur final
- Laboratoires de diagnostic et laboratoires de référence
- Instituts de recherche
- Autres
Marché des services d’histopathologie – par géographie
Amérique du Nord
- NOUS
- Canada
- Mexique
L'Europe
- France
- Allemagne
- Italie
- ROYAUME-UNI
- Espagne
- Le reste de l'Europe
Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie Saoudite
- Émirats arabes unis
- Reste du Moyen-Orient et de l'Afrique
Amérique du Sud (SAM)
- Brésil
- Argentine
- Reste de l'Amérique du Sud et centrale
Profils d'entreprise
- Sonic Healthcare Limitée
- Laboratoire Corporation of America Holdings
- Acculabs Diagnostics UK Ltd.
- Laboratoires de chemin TPL
- UNILABS
- Cureline CRO translationnelle mondiale
- Targos
- Services de pathologie cellulaire,
- Laboratoires de pathologie expérimentale Inc (EPL)
- LABORATOIRES CHARLES RIVER, INC.
Histopathology Services Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 23.89 Billion |
Market Size by | US$ 35.19 Billion |
Global CAGR | 5.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type d'examen
|
Regions and Countries Covered |
Amérique du Nord
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The histopathology services market majorly consists of the players such Sonic Healthcare Limited, Laboratory Corporation of America Holdings, Acculabs Diagnostics UK Ltd, TPL Path Labs, UNILABS, Cureline Global Translational CRO, Targos, Cellular Pathology Services, Experimental Pathology Laboratories Inc (EPL), and CHARLES RIVER LABORATORIES, INC. among others.
The diagnostic laboratories and reference laboratories segment dominated the global histopathology services market and accounted for the largest revenue share of 71.74% in 2021.
The surgical specimen segment dominated the global histopathology services market and held the largest revenue share of 48.51% in 2021.
Global histopathology services market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for histopathology services. The US is estimated to hold the largest share in the histopathology services market during the forecast period. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technological advancements in the diagnosis industry is likely to stimulate the growth of histopathology services market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.
Key factors that are driving the growth of this market include rising demand for biologics and increasing prevalence of chronic diseases.
The List of Companies - Histopathology Services Market
- Sonic Healthcare Limited
- Laboratory Corporation of America Holdings
- Acculabs Diagnostics UK Ltd
- TPL Path Labs
- UNILABS
- Cureline Global Translational CRO
- Targos
- Cellular Pathology Services,
- Experimental Pathology Laboratories Inc (EPL)
- CHARLES RIVER LABORATORIES, INC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.